Multidisciplinary diagnosis and treatment of liver metastases from unresectable colon cancer: a case report and literature review

doi:10.3877/cma.j.issn.2095-3224.2022.06.011

Abstract

Abstract:

In recent years, diagnosis and treatment methods of colorectal cancer, including early and advanced stage, are rapidly progressing in each passing day. In particular, the gradual improvement of the concept of multidisciplinary comprehensive treatment significantly prolongs the OS and PFS of colorectal cancer patients. This report shares a case of an initial unresectable colon cancer with multiple hepatic metastases, who achieved tumor-free survival by pCR through translational therapy and radical surgery under the whole-course management and individualized treatment of MDT.

Key words: Colorectal neoplasms, Neoplasm Metastasis, liver metastasis, Conversion therapy, Multidisciplinary treatment, Pathological complete response

Yefang Lao, Rui He, Rui Zhu, Xiaohui Zhang, Chunrong Zhu. Multidisciplinary diagnosis and treatment of liver metastases from unresectable colon cancer: a case report and literature review[J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2022, 11(06): 516-520.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhjzcjbdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-3224.2022.06.011

https://zhjzcjbdzzz.cma-cmc.com.cn/EN/Y2022/V11/I06/516

Figures/Tables 5

References 15

[1]	Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J]. CA Cancer J Clin, 2021, 71(3): 209-249.
[2]	Siegel RL, Miller KD, Fuchs HE, et al. Cancer statistics, 2022 [J]. CA Cancer J Clin, 2022, 72(1): 7-33.
[3]	Primrose JN. Surgery for colorectal liver metastases [J]. Br J Cancer, 2010, 102(9): 1313-1318.
[4]	Haraldsdottir S, Wu C, Bloomston M, et al. What is the optimal neo-adjuvant treatment for liver metastasis? [J]. Ther Adv Med Oncol, 2013, 5(4): 221-234.
[5]	Tejpar S, Stintzing S, Ciardiello F, et al. Prognostic and predictive relevance of primary tumor location in patients with RAS wild-type metastatic colorectal cancer: retrospective analyses of the CRYSTAL and FIRE-3 trials[J]. JAMA Oncol, 2017, 3(2): 194-201.
[6]	卢婧, 孙祺, 车向明. 潜在可切除的结直肠癌同时性肝转移的治疗策略[J]. 现代肿瘤医学, 2021, 29(18): 3317-3320.
[7]	Andre T, Shiu KK, Kim TW, et al. Pembrolizumab in microsatellite-instability-high advanced colorectal cancer [J]. N Engl J Med, 2020, 383(23): 2207-2218.
[8]	Chalabi M, Fanchi LF, Dijkstra KK, et al. Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancers [J]. Nat Med, 2020, 26(4): 566-576.
[9]	Molla M, Fernandez-Plana J, Albiol S, et al. Limited liver or lung colorectal cancer metastases. systemic treatment, surgery, ablation or SBRT[J]. J Clin Med, 2021, 10(10): 2131.
[10]	Kambakamba P, Hoti E, Cremen S, et al. The evolution of surgery for colorectal liver metastases: A persistent challenge to improve survival [J]. Surgery, 2021, 170(6):1732-1740.
[11]	张炜力, 周驰, 邓宇翔, 等. 初始不可切除结直肠癌肝转移转化治疗结局影响因素分析[J]. 中华胃肠外科杂志, 2022, 25(1): 56-62.
[12]	张钰洋, 陈善稳, 王鹏远, 等. 结直肠癌肝转移转化治疗的研究进展[J]. 中华胃肠外科杂志, 2021, 24(1): 85-93.
[13]	Smith JJ, Strombom P, Chow OS, et al. Assessment of a watch-and-wait strategy for rectal cancer in patients with a complete response after neoadjuvant therapy [J]. JAMA Oncol, 2019, 5(4): e185896.
[14]	Fernandez LM, São Julião GP, Figueiredo NL, et al. Conditional recurrence-free survival of clinical complete responders managed by watch and wait after neoadjuvant chemoradiotherapy for rectal cancer in the International Watch & Wait Database: a retrospective, international, multicentre registry study [J]. The Lancet Oncology, 2021, 22(1): 43-50.
[15]	López-campos F, Martín-martín M, Fornell-pérez R, et al. Watch and wait approach in rectal cancer: Current controversies and future directions[J]. World J Gastroenterol, 2020, 26(29): 4218-4239.

Please choose a citation manager

Content to export